These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 18232651)
1. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones. Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651 [TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents. Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia activated prodrugs of a 9-aza-anthrapyrazole derivative that has promising anticancer activity. El-Dakdouki MH; Adamski N; Foster L; Hacker MP; Erhardt PW J Med Chem; 2011 Dec; 54(23):8224-7. PubMed ID: 22011244 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents. Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs. Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722 [TBL] [Abstract][Full Text] [Related]
6. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline. Shi C; Wang J; Chen H; Shi D J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives. Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles). Krapcho AP; Menta E; Oliva A; Di Domenico R; Fiocchi L; Maresch ME; Gallagher CE; Hacker MP; Beggiolin G; Giuliani FC; Pezzoni G; Spinelli S J Med Chem; 1998 Dec; 41(27):5429-44. PubMed ID: 9876113 [TBL] [Abstract][Full Text] [Related]
9. Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety. Marminon C; Pierré A; Pfeiffer B; Pérez V; Léonce S; Joubert A; Bailly C; Renard P; Hickman J; Prudhomme M J Med Chem; 2003 Feb; 46(4):609-22. PubMed ID: 12570382 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928 [TBL] [Abstract][Full Text] [Related]
11. Antitumor potential of aza-bioisosterism in anthracenedione-based drugs. Sissi C; Palumbo M Curr Top Med Chem; 2004; 4(2):219-30. PubMed ID: 14754455 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues. Defant A; Guella G; Mancini I Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of stable, water soluble radicals as potential anti-cancer agents. Lattmann E; Begum A; Plater MJ Drug Des Discov; 1999 Nov; 16(3):195-201. PubMed ID: 10624565 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of N-substituted derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-8-en-1-yl acetate and screening of cytotoxic activity of selected azatricycloundecane compounds. Kossakowski J; Kuran B Acta Pol Pharm; 2008; 65(3):371-5. PubMed ID: 18646557 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones. Kwak JH; Namgoong K; Jung JK; Han SB; Cho J; Kim HM; Park SG; Lee K; Kang JS; Lee H Arch Pharm Res; 2010 May; 33(5):663-7. PubMed ID: 20512462 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines. Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539 [TBL] [Abstract][Full Text] [Related]
17. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties. Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic evaluation of new derivatives of the marine alkaloid variolin B. Fresneda PM; Delgado S; Francesch A; Manzanares I; Cuevas C; Molina P J Med Chem; 2006 Feb; 49(3):1217-21. PubMed ID: 16451088 [TBL] [Abstract][Full Text] [Related]
19. Oxoazabenzo[de]anthracenes conjugated to amino acids: synthesis and evaluation as DNA-binding antitumor agents. Dias N; Goossens JF; Baldeyrou B; Lansiaux A; Colson P; Di Salvo A; Bernal J; Turnbull A; Mincher DJ; Bailly C Bioconjug Chem; 2005; 16(4):949-58. PubMed ID: 16029036 [TBL] [Abstract][Full Text] [Related]
20. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents. Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]